| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,411,051 | 2,761,167 | 2,875,877 | 2,914,929 | | Cost of Revenue | 350,727 | 398,903 | 423,873 | 503,926 | | | Gross Profit |
-
| 2,362,264 | 2,452,004 | 2,411,003 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,408,106 | 1,488,713 | 1,410,311 | 1,807,547 | | Non Recurring |
-
|
-
|
-
| (236,168) | | Others | 1,126,148 | 997,658 | 1,761,114 | 1,191,582 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (124,107) | (719,421) | (351,958) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (465,195) | (124,107) | (719,421) | (351,958) | | Interest Expense | 169,337 | 204,714 | 243,364 | 304,585 | | Income Before Tax | (650,267) | (328,821) | (962,785) | (656,543) | | Income Tax Expense | (336,056) | (148,957) | (150,777) | (308,956) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (323,696) | (179,864) | (812,008) | (347,587) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (323,696) | (179,864) | (812,008) | (347,587) | | Preferred Stock And Other Adjustments |
-
| 15,436 | (63,373) | (31,634) | | | Net Income Applicable To Common Shares | ($377,144) | ($164,428) | ($875,381) | ($379,221) |
|
0.26% Nasdaq 
0.19 (0.92%) 
Income Statement
